reviewed 93 cases of bilateral CSDHs in which patients underwent unilateral surgery at our institution, and we aimed to determine the factors related to the growth of the contralateral hematoma (the lesion that was not initially treated surgically).
Methods
We retrospectively analyzed 922 consecutive cases involving patients with CSDH who were admitted to the Department of Neurosurgery at Aizu Chuo Hospital (Aizuwakamatsu, Fukushima, Japan), from January 2004 through April 2014. In all cased analyzed in this study, preoperative MRI was performed using a 1.5-T scanner and a spin-echo sequence with repetition and echo times of 525 and 17 msec, respectively, for T1-weighted images and 3600 and 98 msec for T2-weighted images. Bilateral hematoma was identified in 242 of 922 patients. Bur hole surgery was performed bilaterally in 145 patients and unilaterally in 97 patients. Four of the 97 cases were excluded because preoperative T1-and T2-weighted MR images could not be obtained. In these cases, low levels of consciousness prompted urgent bur hole operations, and preoperative MRI was skipped. As a result, 93 cases of unilateral surgery constituted our study group.
Unilateral surgery was performed when the contralateral hematoma was less than 10 mm thick and when the laterality of neurological symptoms could only be attributed to the thicker hematoma (Fig. 1) . Unilateral surgery was also performed in a few cases in which the contralateral hematoma was thicker than 10 mm but was restricted to the frontal side of the subdural space with minimal mass effect. All hematomas were evacuated using a single bur hole procedure and were irrigated and replaced with sterile saline. A closed drainage system using a sterile silicone tube was left in the subdural cavity for 1 day.
Bur hole surgery was performed on the day of hospitalization or the day after in patients receiving antiplatelet or anticoagulant therapy. Vitamin K was administered intravenously when the prothrombin time international normalized ratio (INR) was greater than 1.35, and surgery was performed after confirming that the INR was lower than 1.35. None of the patients received a transfusion of fresh frozen plasma or platelet concentrates. Antiplatelet and anticoagulant treatment was suspended for 3 days to approximately 1 week after surgery, with the duration at the discretion of the physicians in charge.
Based on the preoperative T1-and T2-weighted MR images, we classified the hematomas into 4 groups based on intensity in comparison with gray matter: hyperintense, isointense or hypointense, mixed intensity, and layered pattern (Fig. 2) . Also, the preoperative width of the surgically treated hematoma was measured using maximum in-plane thickness. MRI findings were retrospectively confirmed by 4 of the coauthors subjectively and were discussed thoroughly in cases of conflicting interpretations.
CT scans were performed immediately after bur hole surgery and on the day after surgery in all cases. The next follow-up CT scans were performed between 4 days and 1 week following surgery, after which most patients were discharged home. The interval of subsequent CT scans was established by the physician in charge of treatment and generally fell between 2 and 4 weeks. Follow-up was discontinued when residual hematoma was no longer evident on CT scans or when it shrunk to less than 10 mm in thickness. Six patients were lost to radiographic follow-up, including 2 patients who had residual hematomas greater than 10 mm in thickness. These patients were confirmed to have not experienced symptomatic growth of their hematomas.
Contralateral CSDH was considered to have recurred, or grown, when hematoma enlargement was accompanied by neurological symptoms such as paraplegia, dizziness, headache, and aphasia within 6 months after bur hole surgery. Four cases of asymptomatic hematoma growth were noted on follow-up CT scans, but all of these cases resolved spontaneously and were not considered as "hematoma recurrence" in this study.
Statistical comparisons between groups were performed using Fisher's exact test, and a p value less than 0.05 was considered statistically significant. Multivariate logistic regression analysis was performed using R (version 3.2.1) to assess factors related to hematoma recurrence.
Results
Baseline characteristics of patients are given in Table  1 . The study group included 58 men and 35 women (mean age 78.0 years). In 27 cases, the patients had been receiving antiplatelet or anticoagulation therapy at the time of admission. Of the 93 patients with bilateral CSDH who underwent unilateral surgery, 18 patients (19%) had contralateral hematoma growth that required bur hole surgery. The mean time between the initial operation and the There was no significant association between contralateral hematoma growth (recurrence) and patient age or sex. The recurrence rate for patients receiving anticoagulation or antiplatelet therapy did not differ significantly from that for patients not receiving such therapy (15% vs 21%, p = 0.48). Moreover, the thickness of the drained hematoma did not differ significantly between patients who experienced contralateral hematoma growth and those who did not (21.4 ± 4.8 mm vs 22.4 ± 5.9 mm, p = 0.51), suggesting that the size of the drained hematoma does not contribute to postoperative contralateral growth.
The correlation of MRI findings and hematoma growth is shown in Table 2 . The recurrence rate in patients with hematomas that were iso-or hypointense on T1-weighted MRI was significantly higher than the rate in the other groups combined (35.4% vs 2.3%, p < 0.001). There were no recurrences in patients whose hematomas showed mixed signal intensity or a layered pattern on T1-weighted MR images. Although hematomas that had a mixed-intensity appearance on T2-weighted MR images had a lower growth rate than other groups, we were unable to identify a significant relationship between hematoma growth and T2-weighted imaging classifications.
Multivariate logistic regression analysis showed that 
FIG. 2. Representative axial T1-and T2-weighted MR images (T1WI and T2WI
) showing the classification of hematomas used in this study. Hematomas with uniform intensities were classified as iso-/hypointense or hyperintense in comparison with the intensity of gray matter on both T1-and T2-weighted MR images. Hematomas with diffuse heterogeneous intensity were classified as "mixed" intensity, while hematomas that showed stratification or a clear gradation were classified as "layered."
T1-weighted imaging classification was the only significant factor associated with contralateral hematoma growth. The adjusted odds ratio for hematoma growth in the T1 isointense/hypointense group relative to the T1 hyperintense group was 25.12 (95% CI 3.89-51.58, p < 0.01).
Other factors, such as patient age, sex, T2-weighted imaging findings, the thickness of the drained hematoma, and antiplatelet/anticoagulation therapy were not significantly associated with contralateral hematoma growth ( Table 3) .
Discussion
In our previous study, T1 iso-or hypointense hematomas were confirmed to have a higher postoperative recurrence rate in comparison with T1 hyperintense hematomas. 4 This study confirmed that T1 iso-or hypointense hematomas were also likely to enlarge after contralateral bur hole surgery in patients with bilateral CSDH.
It has been said that preoperative MRI findings have some degree of correlation with the cycle of hematoma growth and hematoma stability. 3 The formation of CSDH is said to start with subdural fluid collection mixed with a blood cell component after trauma or surgery, which causes inflammatory changes in the dura mater, leading to the formation of an outer membrane. 10 Macrocapillaries in the outer membrane surrounding CSDH are highly prone to bleeding and exudation, leading to an intermittent cycle of bleeding, coagulation, and fibrinolysis.
14 Hematoma stability is said to vary depending on the stage of this bleeding cycle.
The MRI appearance of hematomas may be the result of varying stages of hemoglobin degradation, as in intraparenchymal hemorrhage. T1 hyperintensity is thought to reflect free methemoglobin, signifying stable hematoma, 12 while T1 hypo-or isointensity may reflect intracellular deoxyhemoglobin, signifying relatively fresh bleeding. On the other hand, there are reports that T1 hypointensity may signify absorption of free methemoglobin in stable hematomas, 2 and MRI findings may be the result of a complex interaction of several factors. From the results of our study, however, we can assume that T1 hyperintense hematomas are generally stable, while T1 iso-or hypointense hematomas represent more unstable hematomas, which are in the process of rebleeding. In patients with bilateral CSDH undergoing unilateral surgical treatment, meticulous followup may be necessary to evaluate the growth of T1 iso-or hypointense hematomas on the nonoperative side.
Some previous studies have reported that antiplatelet or anticoagulation therapy may play a role in the development of CSDH. Rust et al. 8 reported a high frequency of antiplatelet or anticoagulant therapy in CSDH patients, and a higher rate of recurrence in patients taking aspirin. Lindvall and Koskinen 6 noted a significant association between nontraumatic CSDH and antiplatelet or anticoagulant therapy. However, several previous studies show that there seems to be no significant association between postsurgical CSDH recurrence and the above medications. 4, 6, 13 Antiplatelet or anticoagulant therapy was not a factor of hematoma growth in this study. These results may suggest that these drugs do not play a role in the rebleeding activity of unstable hematomas, although there is a possibility that they have some effect in the formation of hematomas in the first place. The current results imply that we would not need to cease antiplatelet or anticoagulant therapy to prevent postoperative hematoma growth on the nonoperative side, and this treatment may act to decrease the risk of perioperative cerebrovascular events.
Preoperative hematoma thickness 11 and hematoma volume 9 have been reported as factors related to postoperative CSDH recurrence. There are some reported cases of contralateral acute subdural hematomas after drainage of CSDH, 7 in which decompression of intracranial pressure and brain parenchymal shift are thought to contribute to contralateral bleeding. We hypothesized that drainage of thicker CSDHs would result in a rapid reduction in intracranial pressure, contributing to contralateral hematoma growth. However, our results demonstrated that there was no significant relationship between thickness of the drained hematoma and contralateral hematoma growth. The degree of decompression after drainage may be a result of multiple factors, including hematoma thickness, midline shift, patient age, and brain atrophy. Also, it is not clear whether the mechanisms stated above contribute directly to chronic hematoma growth. Therefore, the width of the drained hematoma on its own may not be a useful predictor of contralateral growth.
Other factors investigated in this study, such as patient 
Conclusions
In bilateral CSDH, hypointensity or isointensity on T1-weighted images was confirmed to be associated with a high risk of postoperative CSDH growth on the contralateral side after unilateral surgery, and patients with these imaging findings may require conscientious postoperative follow-up at relatively close intervals. Also, antiplatelet or anticoagulant therapy did not contribute to hematoma growth. It may be better not to cease administration of these medications postoperatively to avoid perioperative cerebrovascular events.
